Anna V. Mathew

4.7k total citations
51 papers, 2.6k citations indexed

About

Anna V. Mathew is a scholar working on Molecular Biology, Physiology and Surgery. According to data from OpenAlex, Anna V. Mathew has authored 51 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Physiology and 8 papers in Surgery. Recurrent topics in Anna V. Mathew's work include Diet and metabolism studies (8 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (5 papers) and Dialysis and Renal Disease Management (4 papers). Anna V. Mathew is often cited by papers focused on Diet and metabolism studies (8 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (5 papers) and Dialysis and Renal Disease Management (4 papers). Anna V. Mathew collaborates with scholars based in United States, China and India. Anna V. Mathew's co-authors include Subramaniam Pennathur, Kumar Sharma, Rose M. Johnstone, Anne‐Émilie Declèves, Jaeman Byun, Anne B. Mason, Katie Teng, Robyn Cunard, Bina Joe and Matam Vijay–Kumar and has published in prestigious journals such as Journal of Biological Chemistry, Blood and The Journal of Immunology.

In The Last Decade

Anna V. Mathew

50 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna V. Mathew United States 23 1.3k 776 434 390 341 51 2.6k
Jae‐Han Jeon South Korea 27 912 0.7× 417 0.5× 201 0.5× 325 0.8× 359 1.1× 93 2.4k
Dilip K. Deb United States 31 1.1k 0.9× 272 0.4× 449 1.0× 371 1.0× 290 0.9× 41 3.3k
Dmitry N. Grigoryev United States 33 1.1k 0.9× 417 0.5× 630 1.5× 419 1.1× 170 0.5× 65 3.4k
Yasumasa Ikeda Japan 34 970 0.8× 448 0.6× 228 0.5× 441 1.1× 412 1.2× 151 3.5k
Akifumi Kushiyama Japan 29 1.2k 0.9× 486 0.6× 367 0.8× 609 1.6× 595 1.7× 98 2.6k
Caifeng Fu United States 9 1.5k 1.1× 544 0.7× 390 0.9× 337 0.9× 1.0k 3.0× 14 4.3k
Davina Judith Burt United Kingdom 18 695 0.5× 514 0.7× 466 1.1× 845 2.2× 636 1.9× 22 2.6k
Wei Jing Liu China 24 911 0.7× 393 0.5× 451 1.0× 790 2.0× 398 1.2× 60 2.4k
Jinping Li China 23 872 0.7× 319 0.4× 375 0.9× 858 2.2× 321 0.9× 85 2.8k
Jawaharlal M. Patel United States 25 765 0.6× 656 0.8× 573 1.3× 511 1.3× 643 1.9× 57 2.6k

Countries citing papers authored by Anna V. Mathew

Since Specialization
Citations

This map shows the geographic impact of Anna V. Mathew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna V. Mathew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna V. Mathew more than expected).

Fields of papers citing papers by Anna V. Mathew

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna V. Mathew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna V. Mathew. The network helps show where Anna V. Mathew may publish in the future.

Co-authorship network of co-authors of Anna V. Mathew

This figure shows the co-authorship network connecting the top 25 collaborators of Anna V. Mathew. A scholar is included among the top collaborators of Anna V. Mathew based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna V. Mathew. Anna V. Mathew is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mathew, Anna V., Yanhong Guo, Jaeman Byun, et al.. (2025). High density lipoprotein particle size and function associate with new cardiovascular events in patients with chronic kidney disease. PLoS ONE. 20(4). e0320803–e0320803.
2.
Shao, Baohai, Anna V. Mathew, Subramaniam Pennathur, et al.. (2021). Altered HDL proteome predicts incident CVD in chronic kidney disease patients. Journal of Lipid Research. 62. 100135–100135. 20 indexed citations
3.
Declèves, Anne‐Émilie, Anna V. Mathew, Aaron M. Armando, et al.. (2019). AMP-activated protein kinase activation ameliorates eicosanoid dysregulation in high-fat-induced kidney disease in mice. Journal of Lipid Research. 60(5). 937–952. 15 indexed citations
4.
Mathew, Anna V., Yanhong Guo, Jaeman Byun, et al.. (2018). Effect of Ambient Fine Particulate Matter Air Pollution and Colder Outdoor Temperatures on High-Density Lipoprotein Function. The American Journal of Cardiology. 122(4). 565–570. 12 indexed citations
5.
Zeng, Lixia, Anna V. Mathew, Jaeman Byun, et al.. (2018). Myeloperoxidase-derived oxidants damage artery wall proteins in an animal model of chronic kidney disease–accelerated atherosclerosis. Journal of Biological Chemistry. 293(19). 7238–7249. 31 indexed citations
6.
Chakraborty, Saroj, Sarah Galla, Xi Cheng, et al.. (2018). Salt-Responsive Metabolite, β-Hydroxybutyrate, Attenuates Hypertension. Cell Reports. 25(3). 677–689.e4. 140 indexed citations
7.
He, Dan, Mingming Zhao, Congying Wu, et al.. (2017). Apolipoprotein A-1 mimetic peptide 4F promotes endothelial repairing and compromises reendothelialization impaired by oxidized HDL through SR-B1. Redox Biology. 15. 228–242. 35 indexed citations
8.
Shen, Haitao, Enchen Zhou, Zhiwei Fu, et al.. (2015). High density lipoprotein promotes proliferation of adipose-derived stem cells via S1P1 receptor and Akt, ERK1/2 signal pathways. Stem Cell Research & Therapy. 6(1). 95–95. 22 indexed citations
9.
Mathew, Anna V., Eric Seymour, Jaeman Byun, Subramaniam Pennathur, & Scott L. Hummel. (2015). Altered Metabolic Profile With Sodium-Restricted Dietary Approaches to Stop Hypertension Diet in Hypertensive Heart Failure With Preserved Ejection Fraction. Journal of Cardiac Failure. 21(12). 963–967. 38 indexed citations
10.
Niewczas, Monika A., Tammy L. Sirich, Anna V. Mathew, et al.. (2014). Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic study. Kidney International. 85(5). 1214–1224. 176 indexed citations
11.
Nampoothiri, Sheela, et al.. (2013). Nail-patella syndrome--a novel mutation in the LMX1B gene. Clinical Kidney Journal. 6(3). 305–307. 2 indexed citations
12.
Mathew, Anna V., Robyn Cunard, & Kumar Sharma. (2011). Antifibrotic Treatment and Other New Strategies for Improving Renal Outcomes. Contributions to nephrology. 170. 217–227. 16 indexed citations
13.
Mathew, Anna V., Shinichi Okada, & Kumar Sharma. (2011). Obesity Related Kidney Disease. Current Diabetes Reviews. 7(1). 41–49. 90 indexed citations
14.
Beier, Ulf H., Bruce Kaplan, Suman Setty, et al.. (2008). Electrolyte Imbalances in Pediatric Living Related Small Bowel Transplantation. Transplantation. 85(2). 217–223. 4 indexed citations
15.
Mathew, Anna V., et al.. (2002). Transmission, host range and etiology of mosaic disease of bitter gourd. Indian Phytopathology. 55(2). 219–220. 5 indexed citations
16.
Mathew, Anna V. & V. Muniyappa. (1993). Host range of Indian cassava mosaic virus. Indian Phytopathology. 46(1). 16–23. 5 indexed citations
17.
Mathew, Anna V., James M. Mathew, & George Mathai. (1991). A whiteflv transmitted mosaic disease of bittergourd. Indian Phytopathology. 44(4). 497–499. 5 indexed citations
18.
Johnstone, Rose M., Anna V. Mathew, Anne B. Mason, & Katie Teng. (1991). Exosome formation during maturation of mammalian and avian reticulocytes: Evidence that exosome release is a major route for externalization of obsolete membrane proteins. Journal of Cellular Physiology. 147(1). 27–36. 254 indexed citations
19.
20.
Lutton, J. D., Anna V. Mathew, R D Levere, & Nader G. Abraham. (1990). Role of heme metabolism in AZT‐induced bone marrow toxicity. American Journal of Hematology. 35(1). 1–5. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026